SCHEMBL30926974

SCHEMBL30926974

O=C(Nc1ccncc1)c1cccc(S(=O)(=O)Nc2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.74
▸ KMT2A Q03164 7/20 0.74
▸ ALDH1A1 P00352 3/20 0.74
▸ SMN1; SMN2 Q16637 2/20 0.74
▸ PKM P14618 2/20 0.74
▸ USP2 O75604 1/20 0.74
▸ LMNA P02545 3/20 0.70
▸ MAPT P10636 1/20 0.70
▸ HDAC2 Q92769 1/20 0.67
▸ HDAC8 Q9BY41 1/20 0.67
▸ HDAC6 Q9UBN7 1/20 0.67
▸ ADORA3 P0DMS8 1/20 0.67
▸ SLC6A3 Q01959 1/20 0.67
▸ NAMPT P43490 1/20 0.60
▸ JAK2 O60674 1/20 0.60
▸ TYK2 P29597 1/20 0.60
▸ THRB P10828 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179653 1.00 MEN1 (0.74) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL30926936 0.92 KMT2A (0.74) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL27181139 0.92 KMT2A (0.74) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL27180894 0.89 MEN1 (0.74) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL27180089 0.88 MAPT (0.76) MEN1KMT2AALDH1A1PKMLMNA
SCHEMBL30926701 0.88 MAPT (0.76) MEN1KMT2AALDH1A1PKMLMNA
SCHEMBL2790669 0.85 MEN1 (0.61) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL4258411 0.85 MEN1 (0.92) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL30926711 0.85 MEN1 (0.92) MEN1KMT2AALDH1A1SMN1; SMN2PKM
SCHEMBL13532168 0.85 MEN1 (0.70) MEN1KMT2AALDH1A1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885ALDH1A1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback